Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis | European Medicines Agency

Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis EMA’s safety committee (PRAC) has concluded that myocarditis and pericarditis can occur in very rare cases following vaccination with the COVID-19 vaccines Comirnaty and Spikevax (previously COVID-19 Vaccine Moderna). The Committee is therefore recommending listing myocarditis and pericarditis as new side effe

[urashimasan]

145myocarditis+138pericarditis/177M-Pz, 19+19/20M-Mod ／cases primarily occurred within 14 days after vaccination, more often after the second dose and in younger adult men